Triplet Immunosuppression for Immune Checkpoint Inhibitor-Related Adverse Events is Associated With High Infection Risk.
- DOI
- 10.6004/jnccn.2026.7068
- Published
- 2026 Sep 24
- Container
- Journal of the National Comprehensive Cancer Network : JNCCN
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.6004/jnccn.2026.7068,
title = {Triplet Immunosuppression for Immune Checkpoint Inhibitor-Related Adverse Events is Associated With High Infection Risk.},
author = {Merkin RD and Lim TL and Restifo D and Rouhani SJ and Pantano L and Lei MM and Zubiri L and Semenov YR and Vilbert M and Peacker BL and Blum SM and Dennis MJ and Buchbinder EI and Hammond SP and Reynolds KL},
year = {2026},
journal = {Journal of the National Comprehensive Cancer Network : JNCCN},
doi = {10.6004/jnccn.2026.7068},
url = {https://doi.org/10.6004/jnccn.2026.7068}
}RIS
TY - JOUR TI - Triplet Immunosuppression for Immune Checkpoint Inhibitor-Related Adverse Events is Associated With High Infection Risk. AU - Merkin RD AU - Lim TL AU - Restifo D AU - Rouhani SJ AU - Pantano L AU - Lei MM AU - Zubiri L AU - Semenov YR AU - Vilbert M AU - Peacker BL AU - Blum SM AU - Dennis MJ AU - Buchbinder EI AU - Hammond SP AU - Reynolds KL PY - 2026 JO - Journal of the National Comprehensive Cancer Network : JNCCN DO - 10.6004/jnccn.2026.7068 UR - https://doi.org/10.6004/jnccn.2026.7068 ER -
APA
RD, M., TL, L., D, R., SJ, R., L, P., MM, L., L, Z., YR, S., M, V., BL, P., SM, B., MJ, D., EI, B., SP, H., & KL, R. (2026). Triplet Immunosuppression for Immune Checkpoint Inhibitor-Related Adverse Events is Associated With High Infection Risk.. Journal of the National Comprehensive Cancer Network : JNCCN. https://doi.org/10.6004/jnccn.2026.7068
Source records
- pubmed · retrieved 2026-09-25T12:18:40.891Z